Clinical Trials on Recurrent Plasma Cell Myeloma in New Zealand
Total 1541 results
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
Icahn School of Medicine at Mount SinaiRecruiting
-
TeneoOne Inc.AbbVieActive, not recruitingMultiple MyelomaUnited States, Germany
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Spain
-
Children's Oncology GroupNational Cancer Institute (NCI); PfizerCompletedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Childhood Anaplastic Large Cell LymphomaUnited States, Canada
-
TakedaActive, not recruitingMultiple MyelomaSpain, United States, Australia, China, Korea, Republic of, Canada, France
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
Millennium Pharmaceuticals, Inc.Completed
-
AmgenCompletedMultiple MyelomaUnited States, Australia
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.Completed
-
CelgeneThe Leukemia and Lymphoma SocietyCompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
AbbVieCompletedMultiple Myeloma (MM)United States, Argentina, Australia, Brazil, Canada, Croatia, Czechia, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovenia, Spain, Taiwan, Turkey
-
BioAtla, Inc.RecruitingHead and Neck Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Recurrent Squamous Cell Carcinoma of the Head and Neck | Metastatic Squamous Cell Carcinoma of the Head and NeckUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Xcyte TherapiesUnknownMultiple MyelomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Netherlands, Italy
-
OncotherapeuticsCelgene CorporationCompletedMultiple MyelomaUnited States
-
Carevive Systems, Inc.RecruitingBreast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Acute Myelogenous LeukemiaUnited States
-
AmgenCompletedMetastatic or Recurrent Squamous Cell Carcinoma of Head and NeckUnited States, Belgium, Czechia, Spain, Austria, France, Lithuania, Puerto Rico, Slovakia
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaBelgium, United States, Japan, Korea, Republic of, Germany, Spain, United Kingdom
-
GlaxoSmithKlineTerminatedMultiple MyelomaUnited States
-
Johnson & Johnson Private LimitedCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Canadian Cancer Trials GroupAmgen; Canadian Myeloma Research GroupCompleted
-
Dartmouth-Hitchcock Medical CenterCompletedRecurrent High Grade GliomasUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingDiarrhea | Multiple MyelomaUnited States
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedTongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditionsUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Italy, Korea, Republic of, Taiwan, China, Germany, Turkey, Japan, France, United Kingdom, Brazil, Spain, Czechia, Poland, Israel, Belgium, Greece, Netherlands
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Canada
-
International Myeloma FoundationJanssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
AmgenCompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
ImmunoGen, Inc.CompletedMultiple MyelomaUnited States, Argentina
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Low Grade Astrocytoma | Refractory Low Grade Astrocytoma | Refractory Low Grade Glioma | Refractory WHO Grade 1 GliomaUnited States, Canada